Topics
News
CME/CE
Editorial Advisory Board
Partnerships
NEW APPROACH PROMISING
A new kind of drug, a Raf kinase inhibitor, is well-tolerated and may prove effective in treating patients with metastatic melanoma, according to researchers from the Abramson Cancer Center of the University of Pennsylvania.
Related Videos
Related Content
